- Home
- Publications
- Publication Search
- Publication Details
Title
G2385R and I2020T Mutations Increase LRRK2 GTPase Activity
Authors
Keywords
-
Journal
Biomed Research International
Volume 2016, Issue -, Pages 1-8
Publisher
Hindawi Limited
Online
2016-05-26
DOI
10.1155/2016/7917128
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- LRRK2 autophosphorylation enhances its GTPase activity
- (2016) Zhiyong Liu et al. FASEB JOURNAL
- Phosphoproteomics reveals that Parkinson's disease kinase LRRK2 regulates a subset of Rab GTPases
- (2016) Martin Steger et al. eLife
- LRRK2 Pathways Leading to Neurodegeneration
- (2015) Mark R. Cookson Current Neurology and Neuroscience Reports
- Cellular processes associated with LRRK2 function and dysfunction
- (2015) Rebecca Wallings et al. FEBS Journal
- An early endosome regulator, Rab5b, is an LRRK2 kinase substrate
- (2015) Hye Jin Yun et al. JOURNAL OF BIOCHEMISTRY
- Sar1 GTPase Activity Is Regulated by Membrane Curvature
- (2015) Michael G. Hanna et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Chemical Biology of Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitors
- (2015) Anthony A. Estrada et al. JOURNAL OF MEDICINAL CHEMISTRY
- Leucine-Rich Repeat Kinase 2 Binds to Neuronal Vesicles through Protein Interactions Mediated by Its C-Terminal WD40 Domain
- (2014) G. Piccoli et al. MOLECULAR AND CELLULAR BIOLOGY
- The role of the LRRK2 gene in Parkinsonism
- (2014) Jie-Qiong Li et al. Molecular Neurodegeneration
- Parkinson disease-associated mutation R1441H in LRRK2 prolongs the "active state" of its GTPase domain
- (2014) J. Liao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The G2385R variant of leucine-rich repeat kinase 2 associated with Parkinson's disease is a partial loss-of-function mutation
- (2012) Iakov N. Rudenko et al. BIOCHEMICAL JOURNAL
- GTPase activity regulates kinase activity and cellular phenotypes of Parkinson's disease-associated LRRK2
- (2012) A. Biosa et al. HUMAN MOLECULAR GENETICS
- LRRK2 I2020T mutation is associated with tau pathology
- (2012) Sachiko Ujiie et al. PARKINSONISM & RELATED DISORDERS
- Impaired Inflammatory Responses in Murine Lrrk2-Knockdown Brain Microglia
- (2012) Beomsue Kim et al. PLoS One
- Re-examination of the dimerization state of leucine-rich repeat kinase 2: predominance of the monomeric form
- (2011) Genta Ito et al. BIOCHEMICAL JOURNAL
- Biochemical and molecular features of LRRK2 and its pathophysiological roles in Parkinson's disease
- (2011) Won-Gi Seol BMB Reports
- LRRK2 directly phosphorylates Akt1 as a possible physiological substrate: Impairment of the kinase activity by Parkinson's disease-associated mutations
- (2011) Etsuro Ohta et al. FEBS LETTERS
- IKBKE Protein Activates Akt Independent of Phosphatidylinositol 3-Kinase/PDK1/mTORC2 and the Pleckstrin Homology Domain to Sustain Malignant Transformation
- (2011) Jian-Ping Guo et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Phosphorylation of LRRK2 serines 955 and 973 is disrupted by Parkinson’s disease mutations and LRRK2 pharmacological inhibition
- (2011) Elizabeth A. Doggett et al. JOURNAL OF NEUROCHEMISTRY
- Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case–control study
- (2011) Owen A Ross et al. LANCET NEUROLOGY
- LRRK2 Kinase Activity Is Dependent on LRRK2 GTP Binding Capacity but Independent of LRRK2 GTP Binding
- (2011) Jean-Marc Taymans et al. PLoS One
- 14-3-3 binding to LRRK2 is disrupted by multiple Parkinson's disease-associated mutations and regulates cytoplasmic localization
- (2010) R. Jeremy Nichols et al. BIOCHEMICAL JOURNAL
- MultipleLRRK2variants modulate risk of Parkinson disease: a Chinese multicenter study
- (2010) Eng-King Tan et al. HUMAN MUTATION
- Identification and Characterization of a Leucine-Rich Repeat Kinase 2 (LRRK2) Consensus Phosphorylation Motif
- (2010) Pooja P. Pungaliya et al. PLoS One
- GTPase Activity Plays a Key Role in the Pathobiology of LRRK2
- (2010) Yulan Xiong et al. PLoS Genetics
- I2020T leucine-rich repeat kinase 2, the causative mutant molecule of familial Parkinson’s disease, has a higher intracellular degradation rate than the wild-type molecule
- (2009) Etsuro Ohta et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Prevention of intracellular degradation of I2020T mutant LRRK2 restores its protectivity against apoptosis
- (2009) Etsuro Ohta et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- The LRRK2 G2385R variant is a risk factor for sporadic Parkinson's disease in the Korean population
- (2009) Jong-Min Kim et al. PARKINSONISM & RELATED DISORDERS
- The WD40 Domain Is Required for LRRK2 Neurotoxicity
- (2009) Nathan D. Jorgensen et al. PLoS One
- Phosphorylation of 4E-BP by LRRK2 affects the maintenance of dopaminergic neurons in Drosophila
- (2008) Yuzuru Imai et al. EMBO JOURNAL
- LRRK2 regulates synaptic vesicle endocytosis
- (2008) Narae Shin et al. EXPERIMENTAL CELL RESEARCH
- Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study
- (2008) Daniel G Healy et al. LANCET NEUROLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now